Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Enterprise Value of -$101.6 million for Q4 2025, up 5.27% year-over-year from -$96.5 million in Q4 2024, and up 5.27% quarter-over-quarter from -$107.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$101.6 million for Q4 2025.
- In Q4 2025, Enterprise Value rose 5.27% year-over-year to -$101.6 million; the TTM figure through Dec 2025 stood at -$101.6 million (up 5.27% YoY), while the FY2025 annual figure was -$101.6 million, up 5.27% from the prior year.
- Enterprise Value for Q4 2025 stood at -$101.6 million, up from -$107.2 million in the prior quarter.
- The five-year high for Enterprise Value was $116.5 billion in Q1 2022, with the low at -$312.5 million in Q1 2021.
- The 5-year median for Enterprise Value is $24.9 million (2024), against an average of $7.7 billion.
- Peak annual rise in Enterprise Value reached 37395.09% in 2022, while the deepest fall reached 758.88% in 2022.
- Curaleaf Holdings' Enterprise Value stood at $45.4 million in 2021, then tumbled by 758.88% to -$299.3 million in 2022, then surged by 109.63% to $28.8 million in 2023, then plunged by 471.9% to -$107.2 million in 2024, then grew by 5.27% to -$101.6 million in 2025.
- Business Quant data shows CURLF's Enterprise Value at -$101.6 million in Q4 2025, -$107.2 million in Q4 2024, and $35.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | -94.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -94.59 Mn |
| Dec 31, 2025 | -101.57 Mn |
| Dec 31, 2024 | -107.23 Mn |
| Sep 30, 2024 | 35.77 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Dec 31, 2023 | 28.83 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 38.28 Mn |
| Dec 31, 2022 | -299.33 Mn |
| Sep 30, 2022 | 118.02 Mn |
| Jun 30, 2022 | 112.14 Mn |
| Mar 31, 2022 | 116.55 Bn |
| Dec 31, 2021 | 45.43 Mn |
| Sep 30, 2021 | -191.28 Mn |
| Jun 30, 2021 | -203.42 Mn |
| Mar 31, 2021 | -312.50 Mn |
| Dec 31, 2020 | -71.45 Mn |
| Sep 30, 2020 | -82.66 Mn |
| Dec 31, 2019 | -44.93 Mn |